Literature DB >> 11200259

A remarkable stabilization of complexes formed by 2,6-diaminopurine oligonucleotide N3'-->P5' phophoramidates.

T Matray1, S Gamsey, K Pongracz, S Gryaznov.   

Abstract

2'-Deoxyribo- and ribo-oligonucleotide N3'-->P5'phosphoramidates containing 2,6-diaminopurine nucleosides were synthesized. Thermal denaturation experiments demonstrated a significant stabilization of the complexes formed by these compounds with DNA and RNA complementary strands, relative to adenosine-containing phosphoramidate counterparts. The increase in melting temperature of the complexes reached up to 6.9 degrees C per substitution. The observed stabilization was attributed to the apparent synergistic effects of N-type sugar puckering of the oligonucleotide N3'-->P5' phosphoramidate backbone, and the ability of 2,6-diaminopurine bases to form three hydrogen bonds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11200259     DOI: 10.1080/15257770008045446

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  3 in total

1.  Formation of stable triplexes between purine RNA and pyrimidine oligodeoxyxylonucleotides.

Authors:  Sergei Ivanov; Yakov Alekseev; Jean-Remi Bertrand; Claude Malvy; Marina B Gottikh
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

2.  A Chemical Approach to Introduce 2,6-Diaminopurine and 2-Aminoadenine Conjugates into Oligonucleotides without Need for Protecting Groups.

Authors:  Mimouna Madaoui; Dhrubajyoti Datta; Kelly Wassarman; Ivan Zlatev; Martin Egli; Bruce S Ross; Muthiah Manoharan
Journal:  Org Lett       Date:  2022-08-16       Impact factor: 6.072

3.  Quantitative assessment of the use of modified nucleoside triphosphates in expression profiling: differential effects on signal intensities and impacts on expression ratios.

Authors:  Allen Nguyen; Connie Zhao; David Dorris; Abhijit Mazumder
Journal:  BMC Biotechnol       Date:  2002-07-31       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.